Company News: Merck (MRK) quarterly results beat analysts’ expectations

Market news

30 July 2019

Company News: Merck (MRK) quarterly results beat analysts’ expectations

Merck (MRK) reported Q2 FY 2019 earnings of $1.30 per share (versus $1.06 in Q2 FY 2018), beating analysts’ consensus estimate of $1.16.

The company’s quarterly revenues amounted to $11.760 bln (+12.4% y/y), beating analysts’ consensus estimate of $10.943 bln.

The company also raised FY 2019 EPS guidance to $4.84-4.94 from $4.67-4.79 versus analysts’ consensus estimate of $4.82 and FY 2019 revenue guidance to $45.2-46.2 bln from $43.9-45.1 bln versus analysts’ consensus estimate of $44.68 bln.

MRK rose to $85.23 (+3.32%) in pre-market trading.

Donald J. Trump@realDonaldTrump: "China is doing very badly, worst year in 27"

U.S. payrolls to rise by 170,000 in July - ING

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.